{"groups":[{"description":"\"Late\" post-autologous stem cell transplant (ASCT) treatment (tremelimumab alone in Cycles 1-2, durvalumab alone in Cycles 3+)","id":"FG000","title":"Cohort 1"},{"description":"\"Early\" post-ASCT treatment (tremelimumab alone in Cycles 1-2, durvalumab alone in Cycles 3+)","id":"FG001","title":"Cohort 2"},{"description":"\"Late\" post-ASCT treatment (tremelimumab + durvalumab in Cycles 1-2, durvalumab alone in Cycles 3+)","id":"FG002","title":"Cohort 3"},{"description":"\"Early\" post-ASCT treatment (tremelimumab + durvalumab in Cycles 1-2, durvalumab alone in Cycles 3+)","id":"FG003","title":"Cohort 4"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"Progressive disease"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}